Search
for

    Sort by

    Research 811–840 of 1000+

    1. Effect of Exogenous Testosterone, Finasteride, and Castration on serum level of Thyroxin PubMed · 2013 · 1 citations
    2. Clinical Pearls in Men's Health Mayo Clinic Proceedings · 2010 · 1 citations
    3. Crystal Structure and Synthesis of 17.ALPHA.-Acetoxy-6,7-epoxypregn-4-ene-3,20-dione X-ray Structure Analysis Online · 2009 · 1 citations
    4. Editorial Comment Urology · 2008 · 1 citations
    5. Étude PCPT : les biais attendus et leur gestion Progrès en Urologie · 2008 · 1 citations
    6. Editorial comment The Journal of Urology · 2005 · 1 citations
    7. Synopsis: 2005 Annual Meeting of the American Society of Andrology Journal of Andrology · 2005 · 1 citations
    8. Alopecia and the Aging Male The Internet Journal of Geriatrics and Gerontology · 2004 · 1 citations
    9. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study. PubMed · 2002 · 1 citations
    10. Effection of Epristeride and Finasteride on Spermatogenesis in Male Rats Yaoxue jinzhan · 2002 · 1 citations
    11. Cyproterone Acetate: A Genotoxic Carcinogen? Pharmacology & Toxicology · 2001 · 1 citations
    12. High-performance liquid chromatographic determination of the enantiomers of the benzoquinolinone LY 191704, a human type 1 5α-reductase inhibitor, in plasma Journal of Chromatography B: Biomedical Sciences and Applications · 1997 · 1 citations
    13. Protective role of agomelatine via modulation of TLR4/NF-κB: NLRP3/IL-1β signaling pathways in testosterone-induced benign prostatic hyperplasia in rats Naunyn-Schmiedeberg s Archives of Pharmacology · 2025
    14. Factors Driving Unique Urination Phenotypes of Male and Female 9-week-old C57BL/6J Mice bioRxiv (Cold Spring Harbor Laboratory) · 2019
    15. Disorders in Male Sexual Differentiation Due to 5α-Reductase-2 Deficiency Elsevier eBooks · 2018
    16. A novel AR molecular glue degrader via bivalent engagement of the N-terminal domain and RNF213–UBE2J2 complex bioRxiv (Cold Spring Harbor Laboratory) · 2026
    17. Impact of a Novel Dehydroepiandrosterone Derivative on the Metabolism of RWPE-1 and LNCaP Cell Lines Oriental Journal Of Chemistry · 2026
    18. The urologic impact of long-term finasteride 1-mg use for androgenic alopecia: a matched-cohort database analysis World Journal of Urology · 2026
    19. Estimating the Effect of Finasteride on Kallikrein Marker Levels in Blood and the Use of Converted Markers in the Four-Kallikrein Model European Urology Focus · 2026
    20. Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of Springer Link (Chiba Institute of Technology) · 2026
    21. Evaluation of residual symptoms and anxiety among patients on therapy for benign prostatic hyperplasia at a Nigerian tertiary healthcare facility Journal of Pharmacy & Bioresources · 2026
    22. Hepatoprotective and anti-hyperplastic effects of silver nanoparticles biosynthesised using aqueous extracts of <i>M. scaber</i> : Insights from acetaminophen and testosterone experimental models E3S Web of Conferences · 2026
    23. Androgenic alopecia and its association with metabolic syndrome University of Zadar Institutional Repository · 2025
    24. Impact of Finasteride on Serum PSA Levels in Men With BPH: A Systematic Review International Journal of Social health · 2025
    25. Bioavailability File: Bicalutamide Fabad Journal of Pharmaceutical Sciences · 2025
    26. MP11-05 THE UROLOGIC IMPACT OF LONG-TERM FINASTERIDE-1 MG USE FOR ANDROGENIC ALOPECIA: A MATCHED-COHORT DATABASE ANALYSIS The Journal of Urology · 2025
    27. Effect of Cuscuta reflexa Extract in Mitigating Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation and Oxidative Stress Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ) · 2025
    28. The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them? MAEDICA – a Journal of Clinical Medicine · 2025
    29. African Journal of Biomedical Research 2025
    30. Patient-reported outcomes, provider-reported outcomes, and physiologic parameters after gender-affirming hormone treatment in Canada: a systematic review HORMONES · 2025